Search

Zhang, Wen Cai, Julie M Wells, Kin-Hoe Chow, He Huang, Min Yuan, Tanvi Saxena, Mary Ann Melnick, et al. 2019. “MiR-147b-Mediated TCA Cycle Dysfunction and Pseudohypoxia Initiate Drug Tolerance to EGFR Inhibitors in Lung Adenocarcinoma.”. Nature Metabolism 1 (4): 460-74.

Mavrikaki, Maria, Eleni Anastasiadou, Recep A Ozdemir, David Potter, Carolin Helmholz, Frank J Slack, and Elena H Chartoff. 2019. “Overexpression of MiR-9 in the Nucleus Accumbens Increases Oxycodone Self-Administration.”. The International Journal of Neuropsychopharmacology 22 (6): 383-93.

Witten, Lisa W, Christopher J Cheng, and Frank J Slack. 2019. “MiR-155 Drives Oncogenesis by Promoting and Cooperating With Mutations in the C-Kit Oncogene.”. Oncogene 38 (12): 2151-61.

Anastasiadou, Eleni, Alberto Faggioni, Pankaj Trivedi, and Frank J Slack. 2018. “The Nefarious Nexus of Noncoding RNAs in Cancer.”. International Journal of Molecular Sciences 19 (7).

Slack, Frank J. 2018. “Tackling Tumors With Small RNAs Derived from Transfer RNA.”. The New England Journal of Medicine 378 (19): 1842-43.

Smith-Vikos, Thalyana, Zuyun Liu, Christine Parsons, Myriam Gorospe, Luigi Ferrucci, Thomas M Gill, and Frank J Slack. 2016. “A Serum MiRNA Profile of Human Longevity: Findings from the Baltimore Longitudinal Study of Aging (BLSA).”. Aging 8 (11): 2971-87.

Pincus, Zachary, Travis C Mazer, and Frank J Slack. 2016. “Autofluorescence As a Measure of Senescence in C. Elegans: Look to Red, Not Blue or Green.”. Aging 8 (5): 889-98.

Adams, Brian D, Eleni Anastasiadou, Manel Esteller, Lin He, and Frank J Slack. 2015. “The Inescapable Influence of Noncoding RNAs in Cancer.”. Cancer Research 75 (24): 5206-10.

McVeigh, Terri P, Song-Yi Jung, Michael J Kerin, David W Salzman, Sunitha Nallur, Antonio A Nemec, Michelle Dookwah, et al. 2015. “Estrogen Withdrawal, Increased Breast Cancer Risk and the KRAS-Variant.”. Cell Cycle (Georgetown, Tex.) 14 (13): 2091-9.

Stahlhut, Carlos, and Frank J Slack. 2015. “Combinatorial Action of MicroRNAs Let-7 and MiR-34 Effectively Synergizes With Erlotinib to Suppress Non-Small Cell Lung Cancer Cell Proliferation.”. Cell Cycle (Georgetown, Tex.) 14 (13): 2171-80.